Research Methodologies Used to Analyze the South Korea Centrifugal Blood Pumps Market

South Korea Centrifugal Blood Pumps Market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with Centrifugal Blood Pumps manufacturers and distributors, retailers, consumer electronics companies, technology providers, and experts to analyze demand trends, technological progress, and competitive activities. Secondary research will involve analyzing reports published by companies and governments, industry journals, technology reports, industry publications, import-export data, and industry organizations in connection, display technologies, and consumer electronics industries. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, price dynamics, and investments.

Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making

What is Decisions Advisors Research?

Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Centrifugal Blood Pumps, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Companies

• Getinge AB.
• LivaNova plc.
• Terumo Corporation.
• Medtronic plc.
• Abbott Laboratories.
• Teleflex Incorporated.
• Abiomed Inc.
• Berlin Heart GmbH.
• Fresenius Medical Care.
• Edwards Lifesciences.
• Insung Medical.

Recent Developments

• In June 2025, South Korea’s Ministry of Food and Drug Safety (MFDS) published its 2024 Medical Device Approval Report, highlighting trends in medical-device approvals and the continued development of advanced cardiovascular and circulatory-support technologies in the Korean medical-device sector.
• In January 2025, a review of extracorporeal centrifugal pumps highlighted continued technological advancements in centrifugal blood pumps for ventricular assist devices (VADs) and extracorporeal membrane oxygenation (ECMO). The development of newer pump generations, including contactless-bearing systems, aims to reduce thrombus formation and improve pump durability.
• In August 2025, the Quantum Perfusion Centrifugal Blood Pump CP20NG with Integrated Sensors received U.S. FDA 510(k) clearance. The system incorporates integrated pressure monitoring and is designed for cardiopulmonary bypass and temporary circulatory support, reflecting continued innovation in sensor-integrated centrifugal blood pump technology.

Market Segmentation

The South Korea centrifugal blood pumps market, By product type

• Portable centrifugal blood pumps.
• Console-based centrifugal pumps.
• ECMO blood pumps.
• Cardiac-surgery pumps.
• Temporary mechanical circulatory-support pumps.

The South Korea centrifugal blood pumps market, By application

• Cardiac surgery.
• ECMO.
• Cardiopulmonary bypass.
• Emergency cardiac support.
• Intensive-care treatment.
• Temporary ventricular support.

The South Korea centrifugal blood pumps market, By end user

• Hospitals.
• Cardiac centers.
• Intensive-care units.
• Specialty clinics.
• Research institutions.

The South Korea centrifugal blood pumps market, By distribution channel

• Direct hospital sales.
• Medical-device distributors.
• Government procurement.
• Service and maintenance contracts.

Expert Views

Experts expect the South Korea centrifugal blood pumps market to grow gradually through 2035. The main factors are cardiovascular disease, advanced cardiac-care facilities, ECMO use, and demand for reliable critical-care devices.

The strongest opportunities are likely to be in ECMO pumps, portable systems, minimally invasive support devices, and locally manufactured extracorporeal products.

However, the market faces challenges such as high equipment costs, strict regulatory requirements, limited specialist training, and dependence on hospital procurement budgets. Companies that provide safe devices, clinical evidence, technical training, and reliable after-sales support are likely to perform best.

Author: Sanket and Pranali By Decisions Advisors and Consulting